Dermatology Times, February 2025 (Vol. 46. No. 02)

Learn more about the in-depth topics covered in the February 2025 print issue of Dermatology Times.

In this CME article, learn more about the interdisciplinary field of psychodermatology and the collaborative health care team necessary for care.

New antiaging dermatology concepts target cellular senescence to slow aging and improve skin health with senotherapeutics.

Key 2025 tax law changes for dermatologists include expiring TCJA provisions, potential rate adjustments, and new deduction policies under Trump.

Explore 2025’s dermatology M&A trends, economic shifts, and key investment drivers shaping the industry's future.

Hawkes discusses urticaria subtypes, treatments, and emerging therapies like dupilumab and remibrutinib.

Trauma-induced melanocyte implantation can lead to subcutaneous melanoma, mimicking melanoma of unknown primary but with distinct diagnostic criteria.

Botox Cosmetic has evolved from its accidental discovery to a leading treatment in dermatology, balancing medical innovation with ethical considerations.

Review emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.

Maximize your AAD 2025 experience with expert tips on education, networking, and navigating the exhibit hall in Orlando.

This review of the latest dermatologic studies includes insights into the efficacy of nutraceuticals in noncystic acne, the role of antimicrobial peptides in the skin barrier, and more.

Start the new year with a look at top dermatology conferences, expert insights, and the latest research on pigmentary disorders, psoriasis, and antiaging treatments.

CD19 CAR T-cell therapy may modulate immune dysregulation in underlying diseases such as psoriasis.

Renata Block, MMS, PA-C; Ted Lain, MD, MBA, FAAD; Zoe Diana Draelos, MD; and Cheri Frey, MD, FAAD, bust common skin care myths in a Dermatology Times custom video series.